539730 — Fredun Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual income statement for Fredun Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	963	1,128	1,316	2,217	2,743
Cost of Revenue
Gross Profit	327	275	251	384	570
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	868	1,062	1,254	2,101	2,490
Operating Profit	94.7	65.7	61.6	117	253
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	61.6	24.9	32.1	86	175
Provision for Income Taxes
Net Income After Taxes	44.6	19	20.1	63.4	108
Net Income Before Extraordinary Items
Net Income	44.6	19	20.1	63.4	108
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	44.6	19	20.1	63.4	108
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	11.6	4.77	6.88	14.2	23
Dividends per Share